Federal appeals court hears CRISPR patent dispute
But in February 2017, the Patent Trial and Appeal Board (PTAB) ruled in favor of the Broad Institute. At a hearing today that ran less than 45 minutes, a lawyer for the UC system asserted that PTAB made a “legal error” in its interpretation of “nonobvious” and asked the appeals... Continue reading